CO-DIAGNOSTIC’S CEO DWIGHT EGAN INTERVIEWED EXCLUSIVELY ON PUBLICWIRE’S “SMALL CAP SPOTLIGHT” PODCAST BROADCASTED GLOBALLY ON PUBLICWIRE.

Egan Discusses Recent Company News, Its Proprietary Molecular Platform and    ORLANDO,FL – Monday, April 23, 2018—PublicWire, announced today its latest exclusive podcast with CEO, Mike Egan of Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, proprietary platform for the development of molecular diagnostics.  The interview on PublicWire’s “Small Cap Spotlight” program features Egan discussing recent company news, CODX’s proprietary molecular platform, competitive market advantage, licensing, its cost effective testing and more.  The interview can be heard here:  The post CO-DIAGNOSTIC’S CEO DWIGHT EGAN INTERVIEWED EXCLUSIVELY ON PUBLICWIRE’S “SMALL CAP SPOTLIGHT” PODCAST BROADCASTED GLOBALLY ON PUBLICWIRE. appeared first on Public Wire.
http://bit.ly/2HpWoBN